The Juvenile Diabetes Research Foundation, the leader in setting the agenda for type 1 diabetes research worldwide and the world’s largest charitable funder and advocate of type 1 diabetes research, announced today Alan J. Lewis, Ph.D., has been named President and Chief Executive Officer. Dr. Lewis, who has more than 30 years of experience in biomedical research, comes to JDRF from Novocell, a cell and drug therapy company focused on diabetes, where he is currently President and Chief Executive Officer. He will join JDRF in January. Join discussion...